Title
What do pregnant women think about influenza disease and vaccination practices in selected countries
Date Issued
01 January 2021
Access level
open access
Resource Type
journal article
Author(s)
Arriola C.S.
Suntarattiwong P.
Dawood F.S.
Soto G.
Das P.
Hunt D.R.
Sinthuwattanawibool C.
Kurhe K.
Thompson M.G.
Wesley M.G.
Saha S.
Hombroek D.
Brummer T.
Kittikraisak W.
Kaoiean S.
Patel A.
Bhargav S.
Khedikar V.
Garg S.
Mott J.A.
Gonzales O.
Cabrera S.
Florian R.
Parvekar S.
Tomyabatra K.
Prakash A.
U.S. Naval Medical Research Unit No. 6
U.S. Naval Medical Research Unit No. 6
U.S. Naval Medical Research Unit No. 6
Publisher(s)
Bellwether Publishing, Ltd.
Abstract
Introduction: We evaluated knowledge, attitudes, and practices (KAP) related to influenza and influenza vaccination among pregnant women in three selected countries. Methods: During 2017, pregnant women seeking antenatal care at hospitals at participating sites were enrolled. We described characteristics and responses to KAP questions. We also evaluated predictors associated with influenza vaccination during pregnancy at sites with substantial influenza vaccine uptake by multivariable logistic regression. Results: Overall, 4,648 pregnant women completed the survey. There were substantial differences among the three survey populations; only 8% of the women in Nagpur had heard of influenza, compared to 90% in Lima and 96% in Bangkok (p-value<0.01). Despite significant differences in sociodemographic characteristics in the three populations, most participants across sites who were aware of influenza prior to study enrollment believe they and their infants are at risk of influenza and related complications and believe influenza vaccination is safe and effective. Half of women in Lima had verified receipt of influenza vaccine compared to <5% in Bangkok and Nagpur (p < .05). For further analysis conducted among women in Lima only, household income above the poverty line (aOR: 1.38; 95%CI: 1.01, 1.88), having 8+ antenatal visits, compared to 0–4 (aOR: 2.41; 95%CI: 1.39, 2.87, respectively), having 0 children, compared to 2+ (aOR: 1.96; 95%CIs: 1.23, 3.12), and vaccination recommended by a health-care provider (aOR: 8.25; 95%CI: 6.11, 11.14) were strongly associated with receipt of influenza vaccine during pregnancy. Conclusions: Our findings identify opportunities for targeted interventions to improve influenza vaccine uptake among pregnant women in these settings.
Start page
2176
End page
2184
Volume
17
Issue
7
Language
English
OCDE Knowledge area
Obstetricia, Ginecología Inmunología Enfermedades infecciosas
Scopus EID
2-s2.0-85099909332
PubMed ID
Source
Human Vaccines and Immunotherapeutics
ISSN of the container
21645515
Sponsor(s)
This study was funded by the U.S. Centers for Disease Control and Prevention through the following funding mechanisms: Cooperative Agreement 1U01GH002084 with Thailand Ministry of Public Health; Interagency Agreements 16FED1612328, 17FED1712076, and 18FED1812054IPD with the U.S. Naval Medical Research Unit No. 6; and Contract # HHSD2002013M53890B with Abt Associates. Open Access funding provided by the Qatar National Library.
Sources of information: Directorio de Producción Científica Scopus